Please login to the form below

Not currently logged in
Email:
Password:

Carolyn Dodd returns to Insight Research Group

Appointed to director-level position almost 20 years after last serving at the research firm

Carolyn Dodd, Insight Research GroupInsight Research Group has appointed Carolyn Dodd to a director-level role almost 20 years after she left the company.

Dodd (pictured right) spent three years at London, UK-based Insight Research Group from 1993 to 1996, before leaving the market research company to join IMS.

She has since worked at a senior level at several healthcare research agencies, including The Planning Shop International and, most recently, Hall & Partners.

Dodds was also a co-founder and research director at Strategic Marketing Europe.

Jane Shirley, CEO of Insight Research Group, said: “We're very pleased to welcome Carolyn back to Insight Research Group as part of the senior team.

“Her pharmaceutical marketing and consultancy skills enable her to approach research challenges from a broader business perspective and to deliver engaging research that is highly valued by our clients.”

21st February 2013

From: Sales, Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics